Adaptive Biotechnologies Corporation

NasdaqGS:ADPT Stock Report

Market Cap: US$2.3b

Adaptive Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ADPT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Dec 25SellUS$367,488Robert HershbergIndividual22,968US$16.00
17 Nov 25SellUS$3,344Kyle PiskelIndividual238US$14.05
16 May 25SellUS$17,149Kyle PiskelIndividual1,929US$8.89
13 Mar 25SellUS$260,932Michelle GriffinIndividual36,291US$7.19
12 Mar 25SellUS$402,270Robert HershbergIndividual53,000US$7.59
06 Mar 25SellUS$1,600,417Chad RobinsIndividual219,569US$7.64
05 Mar 25SellUS$675,219Harlan RobinsIndividual96,656US$6.99
05 Mar 25SellUS$415,540Julie RubinsteinIndividual59,505US$6.99
05 Mar 25SellUS$72,072Kyle PiskelIndividual10,320US$6.99
05 Mar 25SellUS$311,792Sharon BenzenoIndividual44,665US$6.99
05 Mar 25SellUS$181,641Susan BobulskyIndividual26,023US$6.98
05 Mar 25SellUS$145,845Francis LoIndividual20,875US$6.99

Insider Trading Volume

Insider Buying: ADPT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ADPT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,420,5432.77%
Hedge Funds29,993,70818.8%
Institutions125,374,96678.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.5%
Viking Global Investors LP
29,993,708US$455.9m0%1.28%
8.67%
BlackRock, Inc.
13,332,741US$202.7m-0.19%no data
7.34%
The Vanguard Group, Inc.
11,282,152US$171.5m0.06%no data
4.44%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
6,833,137US$103.9m0%0.06%
2.86%
T. Rowe Price Group, Inc.
4,390,489US$66.7m304%0.01%
2.64%
Westfield Capital Management Company, L.P.
4,060,481US$61.7m0%0.26%
2.28%
Geode Capital Management, LLC
3,511,855US$53.4m3.26%no data
2.07%
State Street Global Advisors, Inc.
3,181,644US$48.4m3.32%no data
2%
Lord, Abbett & Co. LLC
3,080,759US$46.8m151%0.14%
1.92%
Invesco Ltd.
2,949,579US$44.8m3,510%0.01%
1.8%
Driehaus Capital Management LLC
2,760,387US$42.0m-8.59%0.2%
1.74%
Jennison Associates LLC
2,674,668US$40.7m104%0.03%
1.68%
Columbia Management Investment Advisers, LLC
2,590,984US$39.4m-56.6%0.01%
1.58%
Arrowstreet Capital, Limited Partnership
2,422,089US$36.8m-0.79%0.02%
1.46%
Fred Alger Management, LLC
2,245,418US$34.1m-10.7%0.14%
1.41%
Wellington Management Group LLP
2,165,327US$32.9m332%0.01%
1.39%
ARK Investment Management LLC
2,138,960US$32.5m-32.4%0.23%
1.3%
Goldman Sachs Asset Management, L.P.
2,003,106US$30.4m35.9%0.01%
1.27%
Amova Asset Management Co., Ltd.
1,947,963US$29.6m-46.6%0.01%
1.26%
Nomura Investment Management Business Trust
1,940,376US$29.5m-7.79%0.04%
1.24%
D. E. Shaw & Co., L.P.
1,902,685US$28.9m158%0.03%
1.2%
Aristotle Atlantic Partners, LLC
1,842,444US$28.0m-41.1%0.91%
1.15%
Blue Water Life Science Advisors, LP
1,765,145US$26.8m-17.7%16.71%
1.13%
Deutsche Asset & Wealth Management
1,734,465US$26.4m1.24%0.01%
1.04%
Chad Robins
1,599,201US$24.3m-13.5%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/22 10:25
End of Day Share Price 2026/02/20 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adaptive Biotechnologies Corporation is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Derik de BruinBofA Global Research
Mark MassaroBTIG
William BonelloCraig-Hallum Capital Group LLC